Aptorum Group Limited (NASDAQ: APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that senior management will present a business overview and update at the upcoming Barclays Global Healthcare Conference on Thursday, March 14th, 2019 at 2:35 p.m. ET.
March 4, 2019
· 1 min read